Effects of Acid-Reducing Agents on the Pharmacokinetics of Lazertinib in Patients with EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.